190 related articles for article (PubMed ID: 20882620)
21. MR findings of focal eosinophilic liver disease using gadoxetic acid.
Lee J; Park CM; Kim KA; Lee CH; Choi JW
Magn Reson Imaging; 2010 Nov; 28(9):1327-34. PubMed ID: 20800984
[TBL] [Abstract][Full Text] [Related]
22. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
23. Hyperintense nodules on non-enhanced T1-weighted gradient-echo magnetic resonance imaging of cirrhotic liver: fate and clinical implications.
Yu JS; Lee JH; Park MS; Kim KW
J Magn Reson Imaging; 2006 Sep; 24(3):630-6. PubMed ID: 16888794
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging.
Choi SH; Byun JH; Lim YS; Yu E; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
J Hepatol; 2016 May; 64(5):1099-1107. PubMed ID: 26820629
[TBL] [Abstract][Full Text] [Related]
25. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
26. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma.
Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kawai K; Kozaka K
J Comput Assist Tomogr; 2011; 35(2):181-6. PubMed ID: 21412087
[TBL] [Abstract][Full Text] [Related]
27. Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI.
Kumada T; Toyoda H; Tada T; Sone Y; Fujimori M; Ogawa S; Ishikawa T
AJR Am J Roentgenol; 2011 Jul; 197(1):58-63. PubMed ID: 21701011
[TBL] [Abstract][Full Text] [Related]
28. Gadobenate dimeglumine-enhanced liver MR imaging in cirrhotic patients: quantitative and qualitative comparison of 1-hour and 3-hour delayed images.
Jeong WK; Byun JH; Lee SS; Won HJ; Kim KW; Shin YM; Kim PN; Lee MG
J Magn Reson Imaging; 2011 Apr; 33(4):889-97. PubMed ID: 21448954
[TBL] [Abstract][Full Text] [Related]
29. Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging?
Haradome H; Grazioli L; Tsunoo M; Tinti R; Frittoli B; Gambarini S; Morone M; Motosugi U; Colagrande S
J Magn Reson Imaging; 2010 Aug; 32(2):334-40. PubMed ID: 20677259
[TBL] [Abstract][Full Text] [Related]
30. Hypovascular hepatic nodule showing hypointensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease: prediction of malignant transformation.
Takayama Y; Nishie A; Nakayama T; Asayama Y; Ishigami K; Kakihara D; Ushijima Y; Fujita N; Hirakawa M; Honda H
Eur J Radiol; 2012 Nov; 81(11):3072-8. PubMed ID: 22673776
[TBL] [Abstract][Full Text] [Related]
31. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
[TBL] [Abstract][Full Text] [Related]
32. Contrast-enhanced dynamic magnetic resonance imaging findings of hepatocellular carcinoma and their correlation with histopathologic findings.
Karahan OI; Yikilmaz A; Artis T; Canoz O; Coskun A; Torun E
Eur J Radiol; 2006 Mar; 57(3):445-52. PubMed ID: 16337762
[TBL] [Abstract][Full Text] [Related]
33. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
34. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
[TBL] [Abstract][Full Text] [Related]
35. Focal eosinophilic infiltration of the liver: gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging.
Ahn SJ; Choi JY; Kim KA; Kim MJ; Baek SE; Kim JH; Song HT
J Comput Assist Tomogr; 2011; 35(1):81-5. PubMed ID: 21160434
[TBL] [Abstract][Full Text] [Related]
36. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
Huppertz A; Balzer T; Blakeborough A; Breuer J; Giovagnoni A; Heinz-Peer G; Laniado M; Manfredi RM; Mathieu DG; Mueller D; Reimer P; Robinson PJ; Strotzer M; Taupitz M; Vogl TJ;
Radiology; 2004 Jan; 230(1):266-75. PubMed ID: 14695400
[TBL] [Abstract][Full Text] [Related]
37. The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI.
Yim H; Yang SG; Jeon YS; Park IS; Kim M; Lee DH; Bae YH; Na K
Biomaterials; 2011 Aug; 32(22):5187-94. PubMed ID: 21561660
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two different injection rates of gadoxetic acid for arterial phase MRI of the liver.
Chung SH; Kim MJ; Choi JY; Hong HS
J Magn Reson Imaging; 2010 Feb; 31(2):365-72. PubMed ID: 20099350
[TBL] [Abstract][Full Text] [Related]
39. Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.
Pastor CM
Radiology; 2010 Nov; 257(2):589. PubMed ID: 20959554
[No Abstract] [Full Text] [Related]
40. Consensus report of the Fifth International Forum for Liver MRI.
Zech CJ; Bartolozzi C; Bioulac-Sage P; Chow PK; Forner A; Grazioli L; Huppertz A; Laumonier H; Min Lee J; Murakami T; Ricke J; Sirlin CB
AJR Am J Roentgenol; 2013 Jul; 201(1):97-107. PubMed ID: 23789662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]